Randomized, double-blinded, placebo-controlled, dose ranging study to assess the immunogenicity and safety of LT [heat-labile enterotoxin of E. coli; Escherichia coli vaccine] application in healthy adults.

Trial Profile

Randomized, double-blinded, placebo-controlled, dose ranging study to assess the immunogenicity and safety of LT [heat-labile enterotoxin of E. coli; Escherichia coli vaccine] application in healthy adults.

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Mar 2012

At a glance

  • Drugs Escherichia coli vaccine (Primary)
  • Indications Enterotoxigenic Escherichia coli infections; Traveller's diarrhoea
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Intercell USA
  • Most Recent Events

    • 07 Sep 2008 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
    • 07 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 27 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top